These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthetic drugs: time to ring the warning bell? Hassen GW; Kalantari H Am J Emerg Med; 2013 Dec; 31(12):1714-5. PubMed ID: 24157073 [No Abstract] [Full Text] [Related]
3. Common drugs of abuse--Part II. Cuddy ML J Pract Nurs; 2004; 54(1):5-8, 25-31; quiz 17-9. PubMed ID: 15193009 [TBL] [Abstract][Full Text] [Related]
4. Ecstasy poisoning. MacConnachie AM Intensive Crit Care Nurs; 1997 Dec; 13(6):365-6. PubMed ID: 9564355 [TBL] [Abstract][Full Text] [Related]
5. Piperazine compounds as drugs of abuse. Arbo MD; Bastos ML; Carmo HF Drug Alcohol Depend; 2012 May; 122(3):174-85. PubMed ID: 22071119 [TBL] [Abstract][Full Text] [Related]
6. [Party drugs cause dangerous poisonings. Risk of serious complications and death]. Knudsen K Lakartidningen; 2011 Feb 2-8; 108(5):207-11. PubMed ID: 21384618 [No Abstract] [Full Text] [Related]
7. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Fineschi V; Masti A Int J Legal Med; 1996; 108(5):272-5. PubMed ID: 8721431 [TBL] [Abstract][Full Text] [Related]
8. [Ecstasy: from recreational drug to toxic substance]. Franck N; Bertrand J Rev Med Liege; 1997 Nov; 52(11):715-22. PubMed ID: 9480498 [No Abstract] [Full Text] [Related]
9. Ecstasy. Hess D; DeBoer S Am J Nurs; 2002 Apr; 102(4):45-7. PubMed ID: 11943922 [No Abstract] [Full Text] [Related]
10. Rave drugs: pharmacological considerations. Klein M; Kramer F AANA J; 2004 Feb; 72(1):61-7. PubMed ID: 15098519 [TBL] [Abstract][Full Text] [Related]
11. [Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants]. Rodríguez Arenas MA; Barrio Anta G; de la Fuente de Hoz L; Royuela L Rev Clin Esp; 1997 Dec; 197(12):804-9. PubMed ID: 9477670 [TBL] [Abstract][Full Text] [Related]
12. Fatality due to the use of a designer drug MDMA (Ecstasy). Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458 [TBL] [Abstract][Full Text] [Related]
13. Ecstasy: creatinine kinase. Hall AP Anaesth Intensive Care; 1997 Oct; 25(5):586-7. PubMed ID: 9352782 [No Abstract] [Full Text] [Related]
14. Legal highs: the dark side of medicinal chemistry. Nichols D Nature; 2011 Jan; 469(7328):7. PubMed ID: 21209630 [No Abstract] [Full Text] [Related]
15. Benzylpiperazine: "A messy drug". Katz DP; Deruiter J; Bhattacharya D; Ahuja M; Bhattacharya S; Clark CR; Suppiramaniam V; Dhanasekaran M Drug Alcohol Depend; 2016 Jul; 164():1-7. PubMed ID: 27207154 [TBL] [Abstract][Full Text] [Related]
16. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Maurer HH; Kraemer T; Springer D; Staack RF Ther Drug Monit; 2004 Apr; 26(2):127-31. PubMed ID: 15228152 [TBL] [Abstract][Full Text] [Related]
17. Syndrome of inappropriate antidiuretic hormone secretion and "designer drugs" (ecstasy). Gómez-Balaguer M; Peña H; Morillas C; Hernández A J Pediatr Endocrinol Metab; 2000 Apr; 13(4):437-8. PubMed ID: 10776999 [No Abstract] [Full Text] [Related]
18. A Case of Unusual Drug Screening Results. Chang BN; Smith MP Clin Chem; 2017 May; 63(5):958-961. PubMed ID: 28455300 [No Abstract] [Full Text] [Related]
19. [Ecstasy, a new designer drug in the techno-scene]. Kuhlmann T Psychiatr Prax; 1996 Nov; 23(6):266-9. PubMed ID: 9036394 [TBL] [Abstract][Full Text] [Related]